Technology Spotlight: Manufacturing Cell Therapy Products - Current and Future Challenges

Posted by

SELECTBIO

Christian Bos, Executive Program Manager, Lonza AG

Abstract
Cell therapy products are currently manufactured in semi-manual processes. These are suitable to provide product for clinical trials and early commercialization phases. Beyond this, cell therapy products will have to be manufactured and processed in truly scalable systems and Lonza is developing such processes.